(Q42237408)

19 October 2017

Lithium's site of action: Clues from side effects (English)

1 reference

https://api.crossref.org/works/10.1016/0010-440X(71)90019-8

15 April 2023

author name string

R. A. O'Connell

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5089644

15 April 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=5089644

15 April 2023

publication date

1 May 1971

1 reference

full work available at URL

19 October 2017

https://api.elsevier.com/content/article/PII:0010440X71900198?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0010-440X(71)90019-8

https://api.elsevier.com/content/article/PII:0010440X71900198?httpAccept=text/plain

15 April 2023

1 reference

https://api.crossref.org/works/10.1016/0010-440X(71)90019-8

15 April 2023

published in

Comprehensive Psychiatry

1 reference

19 October 2017

12

1 reference

19 October 2017

3

1 reference

19 October 2017

224-229

1 reference

Lithium in psychiatric therapy and prophylaxis

19 October 2017

1

1 reference

https://api.crossref.org/works/10.1016/0010-440X(71)90019-8

Lithium-carbonate treatment in depression and mania. A longitudinal double-blind study

15 April 2023

3

1 reference

https://api.crossref.org/works/10.1016/0010-440X(71)90019-8

Lithium Prophylaxis in Recurrent Affective Disorders

15 April 2023

4

1 reference

https://api.crossref.org/works/10.1016/0010-440X(71)90019-8

Prophylactic lithium: double blind discontinuation in manic-depressive and recurrent-depressive disorders.

15 April 2023

5

1 reference

https://api.crossref.org/works/10.1016/0010-440X(71)90019-8

Norepinephrine metabolism and drugs used in the affective disorders: a possible mechanism of action.

15 April 2023

8

1 reference

https://api.crossref.org/works/10.1016/0010-440X(71)90019-8

Lithium-induced thyroid disturbance: Case report and review

15 April 2023

11

1 reference

https://api.crossref.org/works/10.1016/0010-440X(71)90019-8

Contribution to the mode of action of lithium on iodine metabolism

15 April 2023

13

1 reference

https://api.crossref.org/works/10.1016/0010-440X(71)90019-8

Lithium carbonate and plasma cortisol response in the ffective disorders

15 April 2023

15

1 reference

https://api.crossref.org/works/10.1016/0010-440X(71)90019-8

Effect of Lithium-Carbonate Therapy on Adrenocortical Activity

15 April 2023

16

1 reference

https://api.crossref.org/works/10.1016/0010-440X(71)90019-8

Lithium-induced diabetes insipidus-like syndrome

15 April 2023

17

1 reference

https://api.crossref.org/works/10.1016/0010-440X(71)90019-8

Cutaneous Conditions Observed in Patients During Treatment with Lithium

15 April 2023

18

1 reference

https://api.crossref.org/works/10.1016/0010-440X(71)90019-8

Intravenous Glucose Tolerance Test in Depression

15 April 2023

19

1 reference

https://api.crossref.org/works/10.1016/0010-440X(71)90019-8

Manic-Depressive Illness, Diabetes Mellitus, and Lithium Carbonate

15 April 2023

20

1 reference

https://api.crossref.org/works/10.1016/0010-440X(71)90019-8

The catecholamine hypothesis of affective disorders: a review of supporting evidence

15 April 2023

21

1 reference

https://api.crossref.org/works/10.1016/0010-440X(71)90019-8

15 April 2023

Identifiers

1 reference

19 October 2017

1 reference